|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-3-27
|
|
pubmed:abstractText |
We conducted a multicenter phase II trial to determine the efficacy/safety of capecitabine and weekly paclitaxel, a combination with preclinical evidence of synergy, in patients with metastatic breast cancer (MBC) previously treated with a taxane.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic,
http://linkedlifedata.com/resource/pubmed/chemical/Bridged Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids,
http://linkedlifedata.com/resource/pubmed/chemical/capecitabine,
http://linkedlifedata.com/resource/pubmed/chemical/taxane
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1526-8209
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
465-70
|
|
pubmed:meshHeading |
pubmed-meshheading:17386123-Aged,
pubmed-meshheading:17386123-Antimetabolites, Antineoplastic,
pubmed-meshheading:17386123-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:17386123-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17386123-Breast Neoplasms,
pubmed-meshheading:17386123-Bridged Compounds,
pubmed-meshheading:17386123-Chemotherapy, Adjuvant,
pubmed-meshheading:17386123-Deoxycytidine,
pubmed-meshheading:17386123-Drug Administration Schedule,
pubmed-meshheading:17386123-Female,
pubmed-meshheading:17386123-Fluorouracil,
pubmed-meshheading:17386123-Humans,
pubmed-meshheading:17386123-Middle Aged,
pubmed-meshheading:17386123-Paclitaxel,
pubmed-meshheading:17386123-Taxoids
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.
|
|
pubmed:affiliation |
US Oncology Research, Inc, Houston, TX, USA. joanne.blum@usoncology.com
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
